(Q28203306)

English

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

scientific article (publication date: September 2003)

In more languages

Statements

scholarly article

0 references

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation (English)

0 references

0 references

stem cell transplantation

1 reference

based on heuristic

inferred from title

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Martha Wadleigh

1

object named as

Martha Wadleigh

0 references

8

object named as

Joseph H Antin

0 references

Stephanie J. Lee

4

object named as

Stephanie J Lee

0 references

author name string

David Zahrieh

3

0 references

Corey Cutler

5

0 references

Vincent Ho

6

0 references

Paul G. Richardson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738663

31 December 2023

Edwin P. Alyea

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738663

31 December 2023

Richard M. Stone

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738663

31 December 2023

Robert J. Soiffer

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738663

31 December 2023

Daniel J. DeAngelo

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738663

31 December 2023

language of work or name

0 references

publication date

1 September 2003

0 references

8 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738663

31 December 2023

full work available at URL

https://ashpublications.org/blood/article-pdf/102/5/1578/1690363/h81703001578.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738663

31 December 2023

http://ashpublications.org/blood/article-pdf/102/5/1578/1690363/h81703001578.pdf

Portable Document Format

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

0 references

102

0 references

5

0 references

1578-82

0 references

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

1

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy

3

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation

4

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

5

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.

6

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors

10

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Venoocclusive disease of the liver following bone marrow transplantation

11

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Hepatic veno-occlusive disease following hematopoietic stem cell transplantation

12

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms

14

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome

15

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat

16

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Calicheamicin-DNA complexes: warhead alignment and saccharide recognition of the minor groove

18

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor-bearing adult human liver

22

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Supercoiling affects the accessibility of glutathione to DNA-bound molecules: positive supercoiling inhibits calicheamicin-induced DNA damage.

23

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation

24

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation

25

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study

26

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantation

28

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches

29

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist

30

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro

31

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome

33

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Management of hepatic sinusoidal obstruction syndrome following treatment with gemtuzumab ozogamicin (Mylotarg).

34

1 reference

10.1182/BLOOD-2003-01-0255

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0255

31 December 2023

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28203306&oldid=2044276736"